Sourcing 5-Methyl-1,3-Benzenediacetonitrile: HPLC Limits
HPLC Related Substances Limits for 5-Methyl-1,3-benzenediacetonitrile: Isomeric Byproduct Retention Time Windows
When sourcing 5-Methyl-1,3-benzenediacetonitrile (CAS 120511-74-2) for Anastrozole synthesis, procurement managers must scrutinize HPLC related substances limits beyond the standard assay. The critical concern is the separation and quantification of positional isomers, particularly 1-METHYL-3,5-BENZENE-DIACETONITRILE and the 2-methyl analog. These isomers arise during the cyanation of the corresponding bis(chloromethyl) precursor and can co-elute if the HPLC method is not adequately optimized. In our field experience, a C18 column with a mobile phase of acetonitrile/water (gradient from 30% to 70% ACN over 25 minutes) at 1.0 mL/min typically resolves the 5-methyl isomer from the 4-methyl isomer with a resolution factor (Rs) of at least 2.0. However, the 2-methyl isomer often elutes as a shoulder on the main peak, requiring a slower gradient or a phenyl-hexyl column for baseline separation. A non-standard parameter we've observed is that trace levels of the 2-methyl isomer (below 0.10%) can cause a slight increase in the melting point range of the final Anastrozole intermediate, which may affect crystallization behavior. Therefore, a robust specification should include individual limits for each isomeric impurity, not just total related substances. For a deeper dive into how impurities can impact downstream chemistry, see our article on catalyst poisoning risks in Anastrozole reduction.
Impact of Unreacted 5-Methyl-1,3-benzenedicarboxylic Acid Derivatives on API Color Grade and Recrystallization Costs
One often-overlooked impurity in bulk 5-Methyl-1,3-benzenediacetonitrile is the presence of unreacted or partially hydrolyzed 5-Methyl-1,3-benzenedicarboxylic acid derivatives. These acidic species, even at levels as low as 0.5%, can impart a yellow to brown coloration to the final Anastrozole API, pushing it out of the acceptable color grade (typically ≤Y5 per EP). More critically, these acidic impurities can form salts with basic catalysts used in the subsequent reduction step, leading to catalyst poisoning and incomplete conversion. This not only increases recrystallization costs—often requiring multiple solvent systems and charcoal treatments—but also reduces overall yield. In one batch investigation, a 0.8% level of the mono-nitrile mono-acid derivative resulted in a 12% yield loss and an additional two recrystallization steps. Procurement teams should request a specific HPLC method capable of detecting these polar impurities, often using a HILIC column or ion-pairing reagent. The COA should report the sum of all carboxylic acid derivatives, with a recommended limit of ≤0.3%. For Portuguese-speaking stakeholders, we've covered similar prevention strategies in 5-Methyl-1,3-Benzenediacetonitrile: Prevenção De Envenenamento De Catalisador.
Batch-Specific COA Parameters: Assay, Purity, and Impurity Profiling for Bulk Procurement
A standard assay of ≥99.0% by HPLC is insufficient to guarantee performance in Anastrozole synthesis. The batch-specific Certificate of Analysis (COA) must detail the impurity profile with retention times and relative response factors. Below is a typical specification table for industrial-grade 5-Methyl-1,3-benzenediacetonitrile:
| Parameter | Specification | Typical Value |
|---|---|---|
| Assay (HPLC, % area) | ≥99.0 | 99.5 |
| Individual Isomeric Impurity | ≤0.15% | 0.05% |
| Total Carboxylic Acid Derivatives | ≤0.3% | 0.1% |
| Water Content (KF) | ≤0.5% | 0.2% |
| Residual Solvents (GC) | As per ICH Q3C | Class 3 solvents ≤0.5% each |
| Appearance | White to off-white crystalline powder | White powder |
Note that residual solvents like acetonitrile (ACN) are common in this product. The ICH Q3C guideline sets a limit of 410 ppm for ACN (Class 2), but many API manufacturers require tighter in-house limits of ≤100 ppm to avoid solvent accumulation in the final drug substance. Procurement managers should confirm that the supplier's COA includes a statement of compliance with ICH Q3C and provides actual numerical results, not just "conforms." For the exact molecular identity, the IUPAC name is 2-[3-(cyanomethyl)-5-methylphenyl]acetonitrile, and the SMILES is Cc1cc(CC#N)cc(CC#N)c1. Please refer to the batch-specific COA for precise numerical specifications.
Bulk Packaging and Logistics: IBC Totes, 210L Drums, and Handling of Temperature-Sensitive Intermediates
For large-scale procurement, 5-Methyl-1,3-benzenediacetonitrile is typically packed in 25 kg fiber drums or 210L steel drums with polyethylene liners. For ton-scale orders, intermediate bulk containers (IBC totes) of 500 kg or 1000 kg are available. The product is stable at ambient temperature but should be stored at +4°C for long-term stability, as recommended by reference standards. A field-observed non-standard parameter is the tendency of this material to form a hard cake if exposed to humidity during storage, which complicates dispensing. To mitigate this, drums should be purged with nitrogen and sealed with a desiccant bag. During shipping, the product is classified as non-hazardous, but it is sensitive to extreme temperatures; prolonged exposure above 40°C can lead to slight discoloration without significant purity loss. Our logistics team ensures that all shipments include temperature loggers and are accompanied by a certificate of origin (Country of Origin: China). For drop-in replacement scenarios, we match the packaging specifications of original brands to ensure seamless integration into existing production lines.
Drop-in Replacement Strategy: Cost-Efficiency and Supply Chain Reliability for Anastrozole Precursors
As a global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. positions its 5-Methyl-1,3-benzenediacetonitrile as a direct drop-in replacement for established brands like TRC. Our product offers identical technical parameters—CAS 120511-74-2, molecular formula C11H10N2, molecular weight 170.21—while providing significant cost advantages and a more flexible supply chain. By sourcing from our dedicated production lines, procurement managers can reduce lead times and avoid single-supplier risks. The synthesis route we employ is a high-yield cyanation process that minimizes the formation of the problematic 2-methyl isomer, ensuring consistent industrial purity batch after batch. Our manufacturing process is supported by rigorous in-process controls and final QC testing, with full technical support available for method transfer and impurity identification. For those evaluating alternative suppliers, we offer sample batches for qualification and can provide a comprehensive COA package. The stable supply and pharmaceutical grade quality make our product a reliable choice for Anastrozole manufacturers worldwide. Discover more about our high-purity intermediate at our dedicated product page for 5-Methyl-1,3-benzenediacetonitrile.
Frequently Asked Questions
Why do standard assay guarantees fail to predict downstream crystallization issues?
A standard HPLC assay often reports total purity by area normalization, which can mask low-level, non-volatile impurities that act as crystallization inhibitors. For example, isomeric byproducts or acidic derivatives at 0.2% may not significantly affect the assay value but can drastically alter the crystal habit of Anastrozole, leading to poor filtration and yield losses. Procurement teams must verify that the COA includes specific impurity limits and that the HPLC method is capable of separating all known process-related impurities.
Which specific HPLC peaks must procurement teams verify on COAs?
Beyond the main peak, the COA should list retention times and areas for the 2-methyl isomer, the 4-methyl isomer, and any mono-nitrile mono-acid derivatives. The relative retention time (RRT) of the 2-methyl isomer is typically 0.95–0.98 relative to the main peak, making it a critical check. Additionally, any unknown peak above 0.05% should be investigated, as it could be a catalyst residue or a degradation product that affects the subsequent reduction step.
What is the ppm limit for Class 3 solvents?
Class 3 solvents, such as acetone or ethanol, are considered less toxic and have a general limit of 5000 ppm (0.5%) per ICH Q3C. However, for API precursors, many manufacturers apply stricter in-house limits, often 1000 ppm or lower, to ensure compliance with the final drug substance limits.
Is API the same as active ingredient?
Yes, API stands for Active Pharmaceutical Ingredient, which is the biologically active component of a drug product. In the context of this article, Anastrozole is the API, and 5-Methyl-1,3-benzenediacetonitrile is a key intermediate in its synthesis.
What is the ICH limit for ACN?
Acetonitrile (ACN) is a Class 2 solvent with a permitted daily exposure (PDE) of 4.1 mg/day, corresponding to a concentration limit of 410 ppm in the drug substance per ICH Q3C. However, for intermediates, suppliers often target ≤100 ppm to provide a safety margin.
What are the residual solvent limits as per ICH guidelines?
ICH Q3C classifies solvents into three classes: Class 1 (solvents to be avoided), Class 2 (solvents to be limited), and Class 3 (solvents with low toxic potential). Limits for Class 2 solvents are based on PDE and vary by solvent; for example, dichloromethane is 600 ppm, and toluene is 890 ppm. Class 3 solvents are limited to 5000 ppm. The COA should list all residual solvents with their measured concentrations and the ICH limit.
Sourcing and Technical Support
In summary, successful procurement of 5-Methyl-1,3-benzenediacetonitrile hinges on a detailed understanding of HPLC related substances, impurity profiles, and packaging logistics. By partnering with a manufacturer that provides transparent COAs and technical expertise, you can mitigate risks in Anastrozole production and achieve cost efficiencies. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.